Mesenchymal stem cells-based drug delivery systems for diabetic foot ulcer: A review

doi:10.4239/wjd.v14.i11.1585

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 14, Issue 11

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Supplementary Materials of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (3350)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-4) series, Tables (1-1) series.

Item

Count

PDF

WORD

HTML

1942

Figures (1-4)

178

Tables (1-1)

199

Sum=2410

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

145

Download

405

Sum=550

Publishing Process of This Article

Item

Count

Browse

Download

196

Sum=279

Nov 15, 2023 (publication date) through Jul 22, 2024

Times Cited of This Article

Times Cited (1)

Journal Information of This Article

Publication Name

World Journal of Diabetes

ISSN

1948-9358

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Review

World J Diabetes. Nov 15, 2023; 14(11): 1585-1602
Published online Nov 15, 2023. doi: 10.4239/wjd.v14.i11.1585

Open in New Tab Full Size Figure Download Figure

Figure 1 The summary of the main content of this review. MSC: Mesenchymal stem cell; DFU: Diabetic foot ulcer.

Open in New Tab Full Size Figure Download Figure

Figure 2 Themesenchymal stem cells-based drug delivery system for the treatment of diabetic foot ulcer.

Open in New Tab Full Size Figure Download Figure

Figure 3 Illustration of mesenchymal stem cells-derived exosomes in the healing of diabetic foot ulcer[75].

Open in New Tab Full Size Figure Download Figure

Figure 4 Delivery of mesenchymal stem cells and adipose-derived stem cells by hydrogel scaffolds for diabetic foot ulcer[111]. MSC: Mesenchymal stem cells; ASC: Adipose-derived stem cells.

Citation: Zhang HM, Yang ML, Xi JZ, Yang GY, Wu QN. Mesenchymal stem cells-based drug delivery systems for diabetic foot ulcer: A review. World J Diabetes 2023; 14(11): 1585-1602
URL: https://www.wjgnet.com/1948-9358/full/v14/i11/1585.htm
DOI: https://dx.doi.org/10.4239/wjd.v14.i11.1585